Induction of Noxa Sensitizes Human Colorectal Cancer Cells Expressing Mcl-1 to the Small-Molecule Bcl-2/Bcl-xL Inhibitor, ABT-737

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Clinical Cancer Research

• Publication date

  2008-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-08-1665PMID 19088028PMCID PMC2948478
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BH3 mimetic ABT-737 potentiates TRAIL-mediated apoptotic signaling by unsequestering Bim and Bak in human pancreatic cancer cells.

  2008cited by this paper
• Noxa/Mcl-1 balance regulates susceptibility of cells to camptothecin-induced apoptosis.

  2007cited by this paper
• Apoptosis Initiated When BH3 Ligands Engage Multiple Bcl-2 Homologs, Not Bax or Bak

  2007cited by this paper
• The Bcl-2 apoptotic switch in cancer development and therapy

  2007cited by this paper
• Bortezomib, but not cisplatin, induces mitochondria-dependent apoptosis accompanied by up-regulation of noxa in the non–small cell lung cancer cell line NCI-H460

  2007cited by this paper
• Functional Linkage between NOXA and Bim in Mitochondrial Apoptotic Events*

  2007cited by this paper
• Cancer Statistics, 2007

  2007cited by this paper
• Structural insights into the degradation of Mcl-1 induced by BH3 domains

  2007cited by this paper
• Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737.

  2007cited by this paper
• Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism

  2007cited by this paper
• Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma.

  2007cited by this paper
• A novel Bcl-2/Bcl-XL/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma

  2007cited by this paper
• Targeting multiple arms of the apoptotic regulatory machinery.

  2007cited by this paper
• Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation.

  2007cited by this paper
• The Noxa/Mcl-1 axis regulates susceptibility to apoptosis under glucose limitation in dividing T cells.

  2006cited by this paper
• Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia.

  2006cited by this paper
• The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status.

  2006cited by this paper
• The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.

  2006cited by this paper
• An inhibitor of Bcl-2 family proteins induces regression of solid tumours

  2005cited by this paper
• Combined loss of proapoptotic genes Bak or Bax with Bim synergizes to cause defects in hematopoiesis and in thymocyte apoptosis

  2005cited by this paper
• BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly.

  2005cited by this paper
• Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function.

  2005cited by this paper
• Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins.

  2005cited by this paper
• Elimination of Hepatic Metastases of Colon Cancer Cells via p53-Independent Cross-Talk between Irinotecan and Apo2 Ligand/TRAIL

  2004cited by this paper
• Characterization of p53 Wild-Type and Null Isogenic Colorectal Cancer Cell Lines Resistant to 5-Fluorouracil, Oxaliplatin, and Irinotecan

  2004cited by this paper
• p53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa

  2003cited by this paper
• Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity.

  2003cited by this paper
• Resistance of colon cancer cells to long‐term 5‐fluorouracil exposure is correlated to the relative level of Bcl‐2 and Bcl‐XL in addition to Bax and p53 status

  2002cited by this paper
• Synergy of the protein farnesyltransferase inhibitor SCH66336 and cisplatin in human cancer cell lines.

  2001cited by this paper
• Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalysed by caspase-3: a potential feedback loop for amplification of apoptosis-associated mitochondrial cytochrome c release

  2000cited by this paper
• CPT‐11 in human colon‐cancer cell lines and xenografts: Characterization of cellular sensitivity determinants

  1997cited by this paper
• Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts: lack of cross-resistance in vivo in tumors with acquired resistance to the topoisomerase I inhibitor 9-dimethylaminomethyl-10-hydroxycamptothecin.

  1993cited by this paper
• Cancer statistics

  1989cited by this paper
• Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

  1984cited by this paper

• BCL-xL as a therapeutic target in cetuximab-refractory colorectal cancer

  2026cites this paper
• Integrated single-cell and machine learning analysis identifies PMAIP1 as a novel biomarker for predicting prognosis and immunotherapy response in colorectal cancer

  2025cites this paper
• Noxa inhibits oncogenesis through ZNF519 in gastric cancer and is suppressed by hsa-miR-200b-3p

  2024cites this paper
• Shear stress and microRNAs for better metastatic cancer management

  2023cites this paper
• An organic extract from ascidian Ciona robusta induces cytotoxic autophagy in human malignant cell lines

  2023cites this paper
• An integrated approach to understand fluid shear stress-driven and reactive oxygen species-mediated metastasis of colon adenocarcinoma through mRNA-miRNA-lncRNA-circRNA networks

  2022cites this paper
• Expression profiling of anticancer genes in colorectal cancer patients and their in vitro induction by riproximin, a ribosomal inactivating plant protein

  2022cites this paper
• Computational design of an apoptogenic protein that binds BCL-xL and MCL-1 simultaneously and potently

  2022cites this paper
• BH3 Mimetic Sensitivity of Colorectal Cancer Cell Lines in Correlation with Molecular Features Identifies Predictors of Response

  2021cites this paper
• Linking hyperosmotic stress and apoptotic sensitivity

  2020cites this paper
• AT101 [(-)-Gossypol] Selectively Inhibits MCL1 and Sensitizes Carcinoma to BH3 Mimetics by Inducing and Stabilizing NOXA

  2020cites this paper
• Hypertonicity counteracts MCL‐1 and renders BCL‐XL a synthetic lethal target in head and neck cancer

  2020cites this paper
• BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy

  2020cites this paper
• Non-coding RNAs in fluid shear stress-driven and reactive oxygen species-mediated colon cancer metastasis

  2020cites this paper
• NOXA-dependent contextual synthetic lethality of BCL-XL inhibition and “osmotic reprogramming” in colorectal cancer

  2020cites this paper
• Mapping chemotherapeutic drug distribution in cancer cell spheroids using 2D-TOF-SIMS and LESA-TIMS-MS.

  2020cites this paper
• Confounding off-target effects of BH3 mimetics at commonly used concentrations: MIM1, UMI-77, and A-1210477

  2019cites this paper
• SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway

  2019cites this paper
• Cinobufagin, a bufadienolide from traditional Chinese medicine Bufo bufo gargarizans CANTOR, inhibits PC3 cell growth in vitro and in vivo

  2019cites this paper
• Repurposing of mTOR Complex Inhibitors Attenuates MCL-1 and Sensitizes to PARP Inhibition

  2018influential citation
• DNA damage response and repair in colorectal cancer: Defects, regulation and therapeutic implications.

  2018cites this paper
• Cyclin-dependent kinase 2 inhibitor SU9516 increases sensitivity of colorectal carcinoma cells Caco-2 but not HT29 to BH3 mimetic ABT-737.

  2017cites this paper
• Tumor necrosis factor-related apoptosis inducing ligand (TRAIL), a member of the TNF family, is a potential cancer agent due to its tumor-specific induction of apoptosis and human recombinant TRAIL is being tested in clinical trials

  2015cites this paper
• Akt inhibition improves irinotecan treatment and prevents cell emergence by switching the senescence response to apoptosis

  2015cites this paper
• Inhibition des protéines anti-apoptotiques de la famille Bcl-2 par l'ABT-737 : intérêt pour le traitement des cancers des voies aérodigestives supérieures

  2015cites this paper
• Molecular mechanism of anticancer effect of Sclerotium rolfsii lectin in HT29 cells involves differential expression of genes associated with multiple signaling pathways: A microarray analysis.

  2015cites this paper
• The small-molecule compound BM-1197 inhibits the antiapoptotic regulators Bcl-2/Bcl-xL and triggers apoptotic cell death in human colorectal cancer cells

  2015cites this paper
• Antihelminthic benzimidazoles potentiate navitoclax (ABT-263) activity by inducing Noxa-dependent apoptosis in non-small cell lung cancer (NSCLC) cell lines

  2015influential citation
• Novel Therapeutic Strategies for Pancreatic Cancer

  2014cites this paper
• Targeted Inhibition of FAK, PYK2 and BCL-XL Synergistically Enhances Apoptosis in Ovarian Clear Cell Carcinoma Cell Lines

  2014cites this paper
• Differential control of growth, apoptotic activity and gene expression in human colon cancer cells by extracts derived from medicinal herbs, Rhazya stricta and Zingiber officinale and their combination.

  2014cites this paper
• Norcantharidin enhances ABT-263-mediated anticancer activity in neuroblastoma cells by upregulation of Noxa.

  2014cites this paper
• Cancer Therapy : Preclinical Inhibition of NANOG / NANOGP 8 Downregulates MCL-1 in Colorectal Cancer Cells and Enhances the Therapeutic Ef fi cacy of BH 3 Mimetics

  2014cites this paper
• The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin

  2014cites this paper
• Noxa and cancer therapy Tuning up the mitochondrial death machinery in response to chemotherapy

  2014cites this paper
• ATR inhibitors VE-821 and VX-970 sensitize cancer cells to topoisomerase i inhibitors by disabling DNA replication initiation and fork elongation responses.

  2014cites this paper
• Nanoencapsulation of ABT-737 and camptothecin enhances their clinical potential through synergistic antitumor effects and reduction of systemic toxicity

  2014cites this paper
• Melatonin influences pancreatic cancerogenesis.

  2014cites this paper
• The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin

  2014cites this paper
• Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer

  2014cites this paper
• Inhibition of NANOG/NANOGP8 Downregulates MCL-1 in Colorectal Cancer Cells and Enhances the Therapeutic Efficacy of BH3 Mimetics

  2014cites this paper
• Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer Cells

  2014cites this paper
• Noxa and cancer therapy

  2014cites this paper
• Targeting cell death signaling in colorectal cancer: current strategies and future perspectives.

  2014cites this paper
• Clitocine induces apoptosis and enhances the lethality of ABT-737 in human colon cancer cells by disrupting the interaction of Mcl-1 and Bak.

  2014cites this paper
• The Bcl-2/Bcl-XL inhibitor ABT-737 promotes death of retinoblastoma cancer cells

  2013cites this paper
• Leading Small Molecule Inhibitors of Anti-Apoptotic Bcl-2 Family Members

  2013cites this paper
• Survivin Inhibitor YM-155 Sensitizes Tumor Necrosis Factor– Related Apoptosis-Inducing Ligand-Resistant Glioma Cells to Apoptosis through Mcl-1 Downregulation and by Engaging the Mitochondrial Death Pathway

  2013cites this paper
• Extracellular adenosine sensing-a metabolic cell death priming mechanism downstream of p53.

  2013cites this paper
• Caloric restriction modulates Mcl-1 expression and sensitizes lymphomas to BH3 mimetic in mice.

  2013influential citation
• pRb/E2F-1-mediated caspase-dependent induction of Noxa amplifies the apoptotic effects of the Bcl-2/Bcl-xL inhibitor ABT-737

  2013cites this paper
• Simultaneous knock-down of Bcl-xL and Mcl-1 induces apoptosis through Bax activation in pancreatic cancer cells.

  2013influential citation
• Perturbing pro-survival proteins using quinoxaline derivatives: a structure-activity relationship study.

  2012cites this paper
• Noxa/Mcl-1 balance influences the effect of the proteasome inhibitor MG-132 in combination with anticancer agents in pancreatic cancer cell lines

  2012cites this paper
• Bcl-2 inhibitors: emerging drugs in cancer therapy.

  2012cites this paper
• The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition

  2012cites this paper
• Understanding sensitivity to BH3 mimetics: ABT-737 as a case study to foresee the complexities of personalized medicine

  2012cites this paper
• Phosphoinositide 3-kinase/AKT/mTORC1/2 Signaling Determines Sensitivity of Burkitt's Lymphoma Cells to BH3 mimetics

  2012cites this paper
• Cell Cycle , Cell Death and Senescence Phosphoinositide 3-kinase / AKT / mTORC 1 / 2 Signaling Determines Sensitivity of Burkitt ' s Lymphoma Cells to BH 3 mimetics

  2012cites this paper
• Cancer Therapy : Preclinical Tipping the Noxa / Mcl-1 Balance Overcomes ABT-737 Resistance in Chronic Lymphocytic Leukemia

  2012cites this paper
• Involvement of Mcl 1 in diallyl disulfide-induced G 2 / M cell cycle arrest in HL-60 cells

  2012cites this paper
• Methylseleninic acid potentiates multiple types of cancer cells to ABT-737-induced apoptosis by targeting Mcl-1 and Bad

  2012cites this paper
• Upregulating Noxa by ER Stress, Celastrol Exerts Synergistic Anti-Cancer Activity in Combination with ABT-737 in Human Hepatocellular Carcinoma Cells

  2012cites this paper
• Pro-apoptotic activity of BH3-only proteins and BH3 mimetics: from theory to potential cancer therapy.

  2012cites this paper
• Neuroblastome, résistance in vivo à l'irinotecan et voie de signalisation ALK

  2012cites this paper
• Involvement of Mcl1 in diallyl disulfide-induced G2/M cell cycle arrest in HL-60 cells.

  2012cites this paper
• Apoptotic effect of hot water extract of Sanguisorba officinalis L. in human oral cancer cells.

  2012cites this paper
• ABT-737 Synergizes with Arsenic Trioxide to Induce Apoptosis of Gastric Carcinoma Cells In Vitro and In Vivo

  2012cites this paper
• The microenvironment and treatment resistance in chronic lymphocytic leukemia

  2012cites this paper
• Synergistic killing of colorectal cancer cells by oxaliplatin and ABT-737

  2011cites this paper
• The Combination of BH3-Mimetic ABT-737 with the Alkylating Agent Temozolomide Induces Strong Synergistic Killing of Melanoma Cells Independent of p53

  2011cites this paper
• Sensitization of BCL-2–expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737

  2011cites this paper
• Therapeutic Potential and Molecular Mechanism of a Novel, Potent, Nonpeptide, Smac Mimetic SM-164 in Combination with TRAIL for Cancer Treatment

  2011cites this paper
• Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials.

  2011cites this paper
• p53-dependent regulation of Mcl-1 contributes to synergistic cell death by ionizing radiation and the Bcl-2/Bcl-XL inhibitor ABT-737

  2011cites this paper
• Distribution of Bim determines Mcl-1 dependence or codependence with Bcl-xL/Bcl-2 in Mcl-1-expressing myeloma cells.

  2011cites this paper
• Modulation of NOXA and MCL-1 as a Strategy for Sensitizing Melanoma Cells to the BH3-Mimetic ABT-737

  2011cites this paper
• Tipping the Noxa/Mcl-1 Balance Overcomes ABT-737 Resistance in Chronic Lymphocytic Leukemia

  2011cites this paper
• Targeting Mcl-1 for the therapy of cancer

  2011cites this paper
• Deciphering the molecular events necessary for synergistic tumor cell apoptosis mediated by the histone deacetylase inhibitor vorinostat and the BH3 mimetic ABT-737.

  2011cites this paper
• Induction of autophagy-dependent apoptosis by the survivin suppressant YM155 in prostate cancer cells.

  2011cites this paper
• Therapeutic Utility of Proteasome Inhibitors for Acute Leukemia

  2011cites this paper
• Orientadora: Maria Alexandra Núncio de Carvalho Ramos Fernandes, Professora Doutora, FCT/UNL Co-orientadora: Susana Isabel Rodrigues dos Santos, Professora Doutora, IST/UTL

  2011cites this paper
• Improving VSV virotherapy in chronic lymphocytic leukemia with small-molecule BCL-2 inhibitors

  2011influential citation
• Noxa/Bcl-2 Protein Interactions Contribute to Bortezomib Resistance in Human Lymphoid Cells*

  2011cites this paper
• A novel water-soluble gossypol derivative increases chemotherapeutic sensitivity and promotes growth inhibition in colon cancer.

  2010cites this paper
• Clinical Relevance of Apoptotic Regulatory Proteins in Colorectal Cancers

  2010cites this paper
• α-Tocopheryl succinate causes mitochondrial permeabilization by preferential formation of Bak channels

  2010cites this paper
• Melatonin induces pro‐apoptotic signaling pathway in human pancreatic carcinoma cells (PANC‐1)

  2010cites this paper
• Celecoxib-induced apoptosis is enhanced by ABT-737 and by inhibition of autophagy in human colorectal cancer cells

  2010cites this paper
• Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa

  2010cites this paper
• Combined Inhibition of Notch Signaling and Bcl-2/Bcl-xL Results in Synergistic Antimyeloma Effect

  2010cites this paper
• Small mitochondria-targeting molecules as anti-cancer agents.

  2010cites this paper
• Actinomycin D synergistically enhances the efficacy of the BH3 mimetic ABT-737 by downregulating Mcl-1 expression

  2010cites this paper
• Bcl-2 family proteins as therapeutic targets.

  2010cites this paper
• Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists

  2009cites this paper
• Inhibition of MCL-1 enhances Lapatinib toxicity and overcomes lapatinib resistance via BAK-dependent autophagy

  2009cites this paper
• Cytotoxic pentacyclic triterpenoids from Combretum sundaicum and Lantana camara as inhibitors of Bcl-xL/BakBH3 domain peptide interaction.

  2009cites this paper